Raymond James Financial
PLSE icon

Raymond James Financial’s Pulse Biosciences PLSE Stock Holding History

Raymond James Financial’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424K Buy
+15,280
New +$361K ﹤0.01% 4623
2025
Q3 		– Sell
-990
Closed -$14.9K – 6272
2025
Q2 		$14.9K Buy
+990
New +$16.4K ﹤0.01% 5725

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Raymond James Financial's PLSE Position: Q2 2026 in Review

Raymond James Financial opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 15,280 shares worth $424K. The stake represents ﹤0.01% of the portfolio and ranks #4623 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in PLSE as recently as Q2 2025.

Raymond James Financial first reported a position in PLSE in Q2 2025 and has held it in 2 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Raymond James Financial held 15,280 shares of Pulse Biosciences worth $424K as of Q2 2026.
  • Pulse Biosciences was a new Raymond James Financial position in Q2 2026.
  • Pulse Biosciences made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4623 holding.
  • Raymond James Financial first reported a position in Pulse Biosciences in Q2 2025 and has held it in 2 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.